MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202547097773 A) filed by Sartar Therapeutics Oy, Helsinki, on Oct. 10, for 'a pharmaceutical composition for subcutaneous injection of anagrelide.'
Inventor(s) include Van Den Heuvel, Dennie; Ivanitskiy, Katja; and Maksimow, Mikael.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "The present invention is directed to a pharmaceutical composition for subcutaneous injection comprising anagrelide, 3-hydroxy anagrelide or a pharmaceutically acceptable salt thereof including the hydrochloride salt thereof in a solvent comprising a medium-chain triglyc...